The colorectal cancer research group led by Dr. Víctor Moreno at IDIBELL continues to advance the GenRisk project, an initiative aimed at identifying genetic and molecular factors associated with cancer risk and progression, with the
The launch of oloMAP Portal, our bioinformatics platform, marked an important milestone for oloBion, making the analysis and interpretation of metabolomics, lipidomics and proteomics data more accessible for researchers. The platform was developed to address
To conclude a successful 2025, the oloBion team came together for the Samurai Experience. We stepped into the world of the samurai and truly experienced aspects of their discipline and tradition firsthand. We dressed in
Single-omics analyses are often the starting point for exploring specific molecular layers and achieving robust characterization of defined biological changes. However, biological systems are inherently complex and often require a broader analytical perspective to support
On 5–6 November 2025, oloBion participated in the 12th World Congress on Targeting Microbiota, held in Valencia, Spain, as a Gold Sponsor and scientific contributor. The congress is a leading international forum that brings together
The cosmetics and personal care sector is a dynamic and steadily growing market. Trends such as personalized skincare, clean beauty, sustainability, and transparency are reshaping the industry and raising expectations around product performance and the
oloBion has been nominated for the Skin Challenges 2025 Innovation Showcase in recognition of its research exploring proteomic and lipidomic signatures associated with skin ageing and the development of an integrated multi-omics strategy to investigate
On 21 October 2025, oloBion participated in Alibetopías in Madrid, the annual innovation forum organized by FIAB (the Spanish Federation of Food and Beverage Industries), a key meeting point for leaders shaping the future of
In October 2025, oloBion took part in BIOSPAIN 2025, one of Europe’s leading biotechnology partnering events, held 7–9 October at Fira de Barcelona. BIOSPAIN once again highlighted Barcelona’s role as a major innovation hub, bringing
Between 15–18 September 2025, oloBion attended IFSCC 2025 in Cannes, one of the leading international events in cosmetic science. During the congress, we presented a talk focused on a topic that is becoming increasingly central
ConnectionDay25, organized by Catalonia.Health, a key networking event that brings together companies, research centers, health institutions and innovation stakeholders from the life sciences and biotechnology sectors across Catalonia. We were pleased to take part in
oloBion is pleased to announce the publication of a new research article in BMC Plant Biology entitled Unveiling the root–rhizosphere environment of perennial wheat: a metabolomic perspective. Through an untargeted metabolomics approach, the study provides
From June 20 to 26, 2025, the oloBion team attended Metabolomics 2025, a leading international conference organized by Metabolomics Society that brings together renowned experts to discuss the latest advances in metabolomics and their relevance
Last week, the oloBion team took part in Vitafoods Europe 2025, the leading international event dedicated to the nutraceutical industry, which this year was held in our home city of Barcelona. As a laboratory specializing
From April 15 to 17, 2025, our CEO, Paolo Bonini, attended Abu Dhabi Global Health Week 2025, a major initiative led by the Abu Dhabi Department of Health to bring together global leaders, innovators, and
The Institute for Research in Biomedicine (IRB Barcelona) and oloBion have entered into a collaboration agreement to perform advanced metabolomic, proteomic and lipidomic analyses on murine and human tissue and biological fluid samples. This partnership
From 27–30 January 2025, oloBion participated in Arab Health, held at the Dubai World Trade Centre, one of the world’s largest and most influential healthcare exhibitions. The event brings together thousands of healthcare professionals, technology
Mass spectrometry-based omics workflows generate a huge amount of data, which requires a great deal of cleaning and preprocessing before researchers can focus on data visualization and interpretation. Finding new trends and discoveries in omics